Purchase Order HHSN275201000178P
- Not listed
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), which is part of the Department of Health and Human Services (HHS). The contract was awarded to Genscript USA Inc., a small business biotechnology company based in Piscataway, New Jersey, for $11,434.95. The contract has an ultimate completion date of July 30, 2025. Genscript specializes in gene synthesis, gene editing, custom protein and antibody production, and other...
- This federal contract award to Genscript USA Inc., a biotechnology company based in New Jersey, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,196.16 firm fixed-price purchase order is for gene synthesis services. Genscript, a for-profit organization, has a history of providing a wide range of molecular biology products and services to...
- This federal contract award to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, is for the provision of a wide range of molecular biology products and services to support biomedical research and public health initiatives. The $19,395.39 firm fixed-price purchase order contract, awarded by the National Institute of Child Health and Human Development (NICHD), covers gene synthesis, cloning, protein expression and purification, antibody production, and other...
- This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $10,982.04 contract is for the provision of customized protein services, gene synthesis, and other molecular biology products and services to support biomedical research and public health initiatives. The contract does not...
- This federal contract award, valued at $24,999.00, was issued by the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in New Jersey. The contract requires Genscript to generate four stable cell lines, with a final completion date of March 11, 2022. This was a firm fixed-price purchase order, and there was no set-aside designation. Genscript has received...
- This federal contract award, valued at $4,367.10, was issued by the National Institute of Child Health and Human Development (NICHD) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for a firm fixed-price purchase order with a completion date of September 30, 2014. Genscript, which operates as a for-profit organization, has received numerous prime and subcontract awards from various Department of Health and Human Services (HHS) agencies, including...
- This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), to GenScript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $65,963.22 contract is for gene synthesis and related services to support NICHD's research on how transcription factors regulate gene expression and chromatin structure. The award stems from a sole-source special notice solicitation, as NICHD...
- The federal contract HHSN272201600094P was awarded to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $4,035.50 Firm Fixed Price contract was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract does not have a set-aside designation. Under this contract, Genscript is providing a wide range of molecular...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,342.69 firm fixed-price purchase order was awarded to Genscript USA Inc., a biotechnology company based in New Jersey, for gene synthesis and plasmid preparation services. The contract did not have a set-aside designation. Genscript has received numerous prime and...
- This federal contract award, valued at $4,263.55, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in New Jersey. The contract is for the provision of various molecular biology products and services, including gene synthesis, gene editing, custom protein and antibody production, to support biomedical research and public health initiatives. While...
This federal contract award was made by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $4,385.32 firm fixed-price purchase order is for gene synthesis services to support NICHD's research activities. The contract does not have a set-aside designation. Genscript USA Inc. is a for-profit organization that has received numerous prime and subcontract awards from various HHS agencies, including NIH, CDC, and FDA, as well as the USDA, to provide a range of molecular biology products and services for biomedical research and public health initiatives. This includes supplying customized DNA constructs, antibodies, proteins, and other materials to aid vaccine development, therapeutic research, and diagnostic assay creation, particularly for emerging infectious disease threats like COVID-19, influenza, HIV, and Ebola.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 1/20/10 |